Medical/Pharmaceuticals

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ

SHANGHAI, April 20, 2026 /PRNewswire/ -- Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock Exchange on April 17th, 2026, Beijing Time. Alamar (NASDAQ:ALMR) issued shares at a price of $17 per sha...

2026-04-20 10:36 7937

Nuance Pharma Announces Publication of Phase 3 ENHANCE-CHINA Data in the CHEST Journal

Ohtuvayre® (ensifentrine) helped improve lung function in Chinese adult patients in in data published in peer reviewed journal SHANGHAI, April 20, 2026 /PRNewswire/ -- Nuance Pharma ("Nuance" or the "Company") announces that CHEST, the official journal of the American College of Chest Physicians...

2026-04-20 09:00 5421

ACT Genomics Upgrades Clinically Recognized Genomic Test to 101-Gene Panel with 7-Day Turnaround

TAIPEI, April 20, 2026 /PRNewswire/ -- ACT Genomics today announced a significant upgrade to the ACTDrug® series, its next-generation sequencing (NGS) genomic profiling service. The updated panel now covers 101 clinically relevant genes and offers a seven-working-day turnaround time, designed to ...

2026-04-20 09:00 4120

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)

•  The one-year INFUSE study observed patient-reported migraine-related cognitive symptoms at baseline and changes over 6 months in those with at least one prior anti-calcitonin gene-related peptide (anti-CGRP) treatment failure VALBY, Denmark, April 20, 2026 /PRNewswire/ -- H. Lundbeck A/S (Lund...

2026-04-20 01:29 4296

BREAKTHROUGH PRIZE ANNOUNCES 2026 LAUREATES

Six $3 Million Prizes Awarded for Outstanding Discoveries in Life Sciences, Fundamental Physics and Mathematics Gene Therapies for Inherited Blindness, Sickle Cell Disease and Beta-Thalassemia Discovery of Key Genetic Cause of ALS and Frontotemporal Dementia Precision Measurement of Muon's Magn...

2026-04-19 10:38 3531

Ddrops® Supports Children's Healthy Growth at Dripping Colours Montessori Sports Day -- Every Step Toward a Healthier Future

KUALA LUMPUR, Malaysia, April 18, 2026 /PRNewswire/ -- Ddrops® participated in the annual Sports Day hosted by Dripping Colours Montessori on April 18, 2026, reinforcing its commitment to supporting children's healthy growth through active lifestyles and proper ...

2026-04-18 20:00 6428

Antengene Presents Three Novel Programs at AACR 2026, Highlighting Next-Generation ADC and AnTenGager® TCEs

SHANGHAI and HONG KONG, April 18, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune ...

2026-04-18 08:30 7776

ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds

MUNICH, April 18, 2026 /PRNewswire/ -- The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks before b...

2026-04-18 06:01 6123

NYSE Content Update: Defense Tech Company AEVEX to Make Its Public Debut

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 17, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...

2026-04-17 21:42 9595

World Hemophilia Day 2026 - April 17, 2026 - "Diagnosis: First step to care."

MONTREAL, April 17, 2026 /PRNewswire/ -- On April 17, 2026, the global inherited bleeding disorders community will come together on World Hemophilia Day to advocate for all inherited bleeding disorders. This year's theme of  "Diagnosis: First step to care" highlights the critical importance of di...

2026-04-17 13:00 3530

How IBM Quantum is Enabling Healthcare and Biology Research

In the first ever Q4Bio Challenge, research teams sought to demonstrate scalable quantum algorithms for healthcare, with Algorithmiq's work alongside Cleveland Clinic and IBM earning $2 million Q4Bio prize. * Q4Bio aims to accelerate development of quantum algorithms for healthcare that can ru...

2026-04-17 03:09 4077

DOJ Drops All Charges Against Vasudha

The company welcomes dismissal of the case after maintaining its innocence for more than a year HYDERABAD, India, April 17, 2026 /PRNewswire/ -- Vasudha Pharma Chem Limited ("Vasudha" or the "Company"), a leading pharmaceutical bulk drug and intermediate manufacturing company, announced today th...

2026-04-17 02:32 4694

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

* Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. * The new brand structure reflects the scientific journey, connecting early discoveries to translational...

2026-04-16 20:49 4419

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026

SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the leading academic health systems in the United States, will adopt the AI-powered SOPHiA DDM™ Platfo...

2026-04-16 20:00 4240

After 35 Years with Parkinson's Disease and a Life-Threatening Infection, One Patient Reclaimed Independent Living

SHANGHAI, April 16, 2026 /PRNewswire/ -- On World Parkinson's Day, Jiahui International Hospital shares an extraordinary case highlighting advanced Parkinson's disease care complexity, multidisciplinary collaboration, and functional recovery despite life‑threatening complications. A 75‑year‑old ...

2026-04-16 18:59 4287

Mabwell Establishes a Licensing and Commercialization Agreement for Denosumab Biosimilars in Malaysian Market

SHANGHAI, April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has established a licensing and commercialization agreement with a strategic business partner ("the partner") in Malaysia for its...

2026-04-16 17:00 6250

First Ever APAC Pharmacists' Guideline to Tackle Peripheral Neuropathy

Developed By APAC Pharmacist Experts -  1 in 2 diabetics, and 1 in 10 adults suffer from Peripheral Neuropathy [1],[2] -  Community pharmacists first and most accessible point of healthcare contact -  New guidelines highlight emerging role of pharmacists in elevating the standard of care SIN...

2026-04-16 12:00 4201

Global First | NMPA Accepts IND Application for Mabwell's Innovative LILRB4/CD3 TCE Bispecific Antibody 6MW5311

SHANGHAI, April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Administration (NMPA) has accepted the Investigational New Drug (IND) application for its innovative L...

2026-04-16 11:36 7094

Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)

SHANGHAI, April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with a full industry chain, announced that the National Medical Products Administration (NMPA) has accepted supplemental Biologics License Application for MAIWEIJIAN (denosumab injection, R&D cod...

2026-04-16 08:00 4949

Osara Health Publishes New Peer-Reviewed Study Demonstrating Clinically Meaningful Improvements in Physical and Mental Health for People With Cancer

Findings published in JMIR Cancer show measurable health gains for Osara Health participants, adding to a growing evidence base including a 25:1 independently validated return on investment. NEW YORK, April 15, 2026 /PRNewswire/ -- Osara Health

2026-04-15 20:00 3692
1 ... 33343536373839 ... 381